Company Filing History:
1 out of 66 
1 out of 416 
Years Active: 2023
Title: Leyla Fischer: Innovator in Cancer Treatment
Introduction
Leyla Fischer is a prominent inventor based in Gau-Odernheim, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development of bispecific trivalent antibodies.
Latest Patents
Leyla Fischer holds a patent for her invention titled "Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseases." This invention provides binding agents that comprise at least three binding domains. A first binding domain binds to a T cell-specific antigen, while the second and third binding domains bind to a claudin. The methods of using these binding agents or nucleic acids encoding them are aimed at treating cancer.
Career Highlights
Throughout her career, Leyla Fischer has worked with notable companies such as BioNTech SE and Astellas Pharma GmbH. Her work has been instrumental in advancing cancer therapies and improving patient outcomes.
Collaborations
Leyla has collaborated with esteemed colleagues, including Ugur Sahin and Christiane Regina Stadler, to further her research and development efforts in the field of oncology.
Conclusion
Leyla Fischer's innovative work in developing bispecific trivalent antibodies represents a significant advancement in cancer treatment. Her contributions continue to impact the medical field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.